Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Contest Catch the Monkey 12.06.2021

1

Log in

Login with your sharewise account or sign up for a free account now

Show more
2

Issue 5 predictions

The first 5 predictions you issue after the contest starts automatically take part in the contest

Show more
3

Win

Keep an eye on the ranking to see if you're amongst the winners. The top spots are rewarded with attractive prices.

Show more

Vassago1 scored a decisive win in our stockpicking contest Catch the Monkey 12.06.2021 ahead of skyrockerZoe with a performance of 37.298%. KongVestor had a hard time, his performance of 7.396% was only enough for position 13 on the leaderboard.

We discuss all securities, matching the rule For 5 securities, where you also told the community the pros and cons you get 1% extra performance

The most often selected stocks in this stockpicking contest were AMC Entertainment Holdings Inc., Tesla Inc and Bitcoin. AMC Entertainment Holdings Inc. was selected 10 times, Tesla Inc was picked 8 times and Bitcoin 8 times. The best predictions were Buy Washington Prime Group Inc. by Global_Player, Buy AMC Entertainment Holdings Inc. by AlexKlar and Buy 1847 Goedeker Inc. by skyrockerZoe. Buy Washington Prime Group Inc. had a performance of 212.849%, followed by Buy AMC Entertainment Holdings Inc. with 77.158%, and Buy 1847 Goedeker Inc. managed to achieve a performance of 65.161%.

Create 5 predictions to join
#
Username
Performance including bonus
Name Prediction Start price Perf. (%)
Annovis Bio Inc. buy €36.80 56.250%
AC Immune Ltd buy €4.92 18.245%
Biogen Inc. buy €221.25 48.000%
Cassava Sciences Inc. buy €45.09 40.918%
Anavex Life Sciences Corp buy €10.40 23.077%
Name Prediction Start price Perf. (%)
Adverum Biotechnologies Inc. buy €2.86 3.497%
Shineco Inc. buy €6.35 -9.449%
Viridian Therapeutics Inc. buy €14.50 -8.276%
HyreCar buy €13.60 15.441%
1847 Goedeker Inc. buy €1.55 65.161%
Name Prediction Start price Perf. (%)
Horizen sell €93.73 -28.559%
Decred sell €117.46 -1.767%
Maker sell €2,733.2 -11.034%
Monero sell €235.36 -12.311%
Zcash sell €144.12 -27.445%
Name Prediction Start price Perf. (%)
1847 Goedeker Inc. buy €1.55 61.290%
Englobal buy €3.06 -24.183%
Orbital Energy Group Inc. buy €4.46 -8.072%
Vertex Energy Inc. sell €8.60 -23.256%
Odonate Therapeutics Inc. buy €2.80 7.143%
Name Prediction Start price Perf. (%)
Adler Modemärkte AG sell €1.35 -2.231%
Polkadot [IOU] buy €17.34 0.727%
Bitcoin buy €26,888 14.663%
Braincloud AG buy €16.10 5.590%
windeln.de SE sell €5.64 -48.936%
Name Prediction Start price Perf. (%)
XpresSpa Group Inc. buy €1.10 25.773%
Corvus Pharmaceuticals Inc buy €2.18 2.752%
Ziopharm Oncology buy €2.44 -2.459%
Aravive, Inc. buy €4.16 6.250%
Molecular Templates Inc. buy €7.24 0.967%
Name Prediction Start price Perf. (%)
Moderna Inc. buy €162.02 11.517%
Austria Microsystems AG buy €17.14 1.225%
Tesla Inc buy €478.85 5.169%
Plug Power Inc. buy €25.10 4.762%
Sunworks Inc. buy €7.51 9.028%
Name Prediction Start price Perf. (%)
Vertex Energy Inc. sell €8.60 -23.256%
Adler Modemärkte AG buy €1.27 1.544%
XpresSpa Group Inc. buy €1.15 20.304%
AMC Entertainment Holdings Inc. sell €52.66 -24.824%
Sundial Growers Inc. buy €1.20 -27.350%
Name Prediction Start price Perf. (%)
AMC Entertainment Holdings Inc. sell €39.34 3.305%
Monero buy €224.61 -7.712%
Covanta Holding Corp. sell €14.40 1.250%
Biogen Inc. buy €321.00 2.057%
windeln.de SE sell €4.25 -32.235%
Name Prediction Start price Perf. (%)
M1 Kliniken AG buy €10.35 10.145%
Helma Eigenheimbau AG buy €55.00 -1.455%
Haemato AG buy €29.20 -5.137%
Deutsche Rohstoff AG buy €14.90 8.054%
Vizsla Silver Corp. buy €1.64 4.281%

Comments

Vielen Dank @skyrockerZoe und ebenfalls Glückwunsch zum zweiten Platz 💐 🥈
Meine aducanumab-Wette ist gut aufgegangen, dass war der Grundstein des Erfolgs. 📈


Show more

Gratulation an Vassago1    Mr. Biotech Klarer Sieg !!!!
Show more

The Motley Foll berichtet über Adverum

Sie sehen sie nur als Beobachtungsaktie

 
  1. Ende April gab Adverum bekannt, dass seine experimentelle Gentherapie für diabetisches Makulaödem (DME), bekannt als ADVM-022, in seiner laufenden Mid-Stage-Studie auf einen ernsthaften Haken gestoßen ist. Insbesondere soll ein Patient in der Studie Hypotonie (niedriger Augeninnendruck) und Sehverlust im behandelten Auge entwickelt haben, was das Unternehmen dazu zwang, sein klinisches Programm für ADVM-022 zu überdenken.
  2. Als direkte Folge dieses unerwarteten klinischen Rückschlags veröffentlichte Sonic Fund II, ein Hauptaktionär des Unternehmens, eine vernichtende Pressemitteilung, in der die Ernennung von drei neuen Vorstandsmitgliedern zur Überwachung der klinischen Entwicklung von ADVM-022 gefordert wurde. 
Show more

Finished contests